OPTIMISE-CKD Study_current clinical landscape in Spain

Trial Identifier:	D169AR00032
Sponsor:	AstraZeneca
Start Date:	December 2024
Primary Completion Date:	May 2025
Study Completion Date:	May 2025
Condition:	Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Spain, Spain	Sevilla, Spain, Spain, 41092

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.